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A
recent (January 2010) editorial in The Lancet
addressing the ‘perils of journal and supplement
publishing’ states in no unclear terms that the
publishing of commercially sponsored supplements is
‘firmly off the agenda’ for The Lancet (1). The editorial
notes that although supplements and custom publica-
tions are an established element in journal publishing,
supplemental material ‘is usually much inferior to that of
any parent title’ and is generally problematic for editors
and reviewers. On this note, The Lancet goes on to
identify examples of commercial supplement publications
that support this view, including a recent example that
had fallen into their own hands.
The Lancet is not the only entity to address custom
publications this winter. Elsevier, the publisher behind
The Lancet, found itself at the center of controversy and
criticism in 2009 when it was revealed that a custom
publication was sponsored by a pharmaceutical company
without this information being disclosed to readers. In
the wake of this incident, Elsevier chose to review its
internal policies and procedures for custom and spon-
sored publications, leading to both an introduction of
new and practical elements to these and to a decision to
make these policies and procedures public (see announce-
ment). These actions recognized the increasing demand
for transparency that is being heard throughout the
scholarly communications arena.
Debate over supplemental materials, invited articles
and custom publications rises occasionally in scientific
publishing, particularly in bio-medical fields. At the heart
of most criticism is a concern over whether our usual
mechanisms of quality control  in particular, stringent
peer review  have been foregone in the interests of
attaining financial gain. Moreover, and following from
this, questions arise about publications that have not been
subjected to critical review but are being presented as
scientifically rigorous alongside other publications that
have been. In short, are we being duped into trusting an
article that reports positively on a drug because the
company that developed and/or produces that drug has
paid a high enough fee to a journal or communications
company to publish the material in  or as supplemental
material to  an otherwise esteemed journal?
Unlike The Lancet, Global Health Action has deliber-
ately and firmly placed supplemental publications on its
agenda, welcoming Supplements to and Themed Clusters
of Papers in the journal. Though a fairly new journal, we
have already published two supplements (2, 3) and a
thematic cluster of articles (4), and at least two more
supplements and a thematic cluster are pending for
publication in 2010. The editors and the publisher not
only welcome supplemental publications but actively
pursue and develop such content as we regard this to
be in line with the aims of the journal, not least of which
is its intent to publish the critical results of research being
conducted by colleagues in developing countries who
are often disadvantaged in terms of publishing. We also
firmly believe that thematic series of papers may serve
research training purposes for young researchers from
developing countries and foster collaborative networking
in research across cultures and disciplines. We can further
this aim by being attuned to key projects that are being
carried out in such settings, to issues that urgently need to
be addressed, and to gaps in knowledge that need to be
filled, through offering a publication outlet for these,
while also maintaining usual quality standards.
The special publication of a cluster of articles addres-
sing climate change and global health in conjunction with
the COP 15 climate meeting that was held in Copenhagen
last December is an example of our efforts in this area (4).
As the climate debate raged on, few voices were addres-
sing the urgent question of what impact changes in global
climate might have upon the health of people across the
globe. In response, Global Health Action invited two well-
respected and internationally recognized researchers to
edit a cluster of papers on this subject and to help us to
recruit researchers to submit manuscripts on the topic.
The result was a highly interesting collection of articles
which  apart from being published online  was also
printed in 600 copies as a Special Volume for distribution
to key players at COP 15. These articles have been read
by visitors in over 170 countries who have downloaded
the complete collection (24 articles) some 2,300 times,
in addition to thousands of individual papers as single
items. The print publication of these articles was spon-
sored by the Umea ˚ Centre for Global Health Research,
one of the partners behind Global Health Action.
To date, the supplements published in Global Health
Action have received different forms of sponsorship,
though none of this has been from the industry or others
withcommercialvestedinterests.Tothecontrary,sponsor-
ship has largely come from governmental and non-profit
entities that appreciate the work we are striving to carry
out, including the Wellcome Trust, Sida/GLOBFORSK,
Rockefeller Foundation, Gates Foundation, the Hewlett
Foundation, the Centre for Global Health Research at
Umea ˚ University, Sweden, and the Norwegian organizers
behind the abstract supplement from the Second Con-
ference on Global Health Research (2).
We agree with Elsevier that the routines and guidelines
behind supplemental or custom publications should be as
transparent as possible. As noted above, all materials
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Global Health Action are submitted to our regular peer
review process involving at least two independent re-
viewers, using a single blind process (i.e. the reviewers’
identities remain unknown to the authors). Some pub-
lished works are also developed, prior to peer review,
through our mentor program. This mentor program was
developed on the basis of the editorial team’s and the
publisher’s commitment to seek important research
results from all areas of the globe on global health, while
also ensuring high-quality content. The mentor program
is aimed at lifting the quality of scientific writing
and presentation of results by young or inexperienced
researchers. A core group of high-ranking, dedicated
researchers have volunteered to occasionally work with
authors who have submitted manuscripts that are highly
promising, but which require some additional work to
bring the article in line with the journal’s expectations
and international standards. An example of such mentor-
ship is the 2009 supplement Risk factors for chronic non-
communicable disease: the burden in Asian INDEPTH
Health and Demographic Surveillance Sites (3) for which
Professor Ruth Bonita served as mentor for many of the
authors.
To summarize, Global Health Action’s perspective on
supplemental materials is quite different from that of
The Lancet; supplemental materials can be of both high
quality and help a journal fulfill its stated mission.
Readers can be assured that all articles and reports
published in Global Health Action have been and will be
subjected to regular peer review and that any external
funding that has been used to support the publication of
additional materials will be specified.
Stig Wall and Peter Byass, Editors
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